Search
for
Sort by
Research 961–990 of 1000+
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Update on the dermatologic use of systemic glucocorticosteroids
- Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- Association of AR rs6152G/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women
- Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin
- Rational investigations in the diagnosis and management of women with hirsutism or androgenetic alopecia
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Factors in the etiopathogenesis of post-adolescent female acne
- Hormonal Treatment for Skin Androgen-Related Disorders
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- Hormonal treatment of acne vulgaris: an update
- Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Pathobiology of chemotherapy-induced hair loss
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Cutaneous signs in COVID ‐19 patients: A review
- Cutaneous complications of chemotherapeutic agents
- Health-related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36)
- Metabolic risk in PCOS: phenotype and adiposity impact
- Complex Hair Cycle Domain Patterns and Regenerative Hair Waves in Living Rodents
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research